Increased human neutrophil lipocalin and its clinical relevance in adult-onset Still's disease

Ji LI; Yingni LI; Ru LI; Xiangbo MA; Lianjie SHI; Shengguang LI; Qian GUO; Yuan JIA; Zhanguo LI.
Chinese Medical Journal ; (24): 2867-2873, 2023.
Artículo en Inglés | WPRIM | ID: wpr-1007552

Documentos relacionados

  1. Increased human neutrophil lipocalin and its clinical relevance in adult-onset Still's disease.
  2. Neutrophil activation biomarker pentraxin 3 for diagnosis and monitoring of macrophage activation syndrome occurrence in adult-onset Still's disease.
  3. Neutrophil-derived lipocalin-2 in adult-onset Still's disease: a novel biomarker of disease activity and liver damage.
  4. Up-regulation of CD64 Expression on Monocytes in Patients With Active Adult-Onset Still Disease: A Possible Biomarker of Disease Activity.
  5. mCRP as a Biomarker of Adult-Onset Still's Disease: Quantification of mCRP by ELISA.
  6. ["STILL IS NOT ENOUGH" - WHAT IS THE DIFFERENTIAL DIAGNOSIS AND THE WORKUP WHEN THE FERRITIN LEVEL IS EXTREMELY HIGH?]
  7. Serum leucine-rich α2-glycoprotein is a useful biomarker for monitoring disease activity in patients with adult-onset Still's disease.
  8. Dual effects of interleukin-10 on natural killer cells and monocytes and the implications for adult-onset Still's disease.
  9. Cellular and transcriptional dynamics of human neutrophils at steady state and upon stress.
  10. IL-18 in Autoinflammatory Diseases: Focus on Adult Onset Still Disease and Macrophages Activation Syndrome.